Mangoceuticals
MGRX
5 hedge funds and large institutions have $34.9K invested in Mangoceuticals in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
0% less ownership
Funds ownership: 0.05% → 0.05% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
44% less funds holding
Funds holding: 9 → 5 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
74% less capital invested
Capital invested by funds: $136K → $34.9K (-$101K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$18K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$13K |
| 3 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$9.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGAM
Desjardins Global Asset Management
Montreal,
Quebec, Canada
|
-$25.1K |
| 2 |
VF
Virtu Financial
New York
|
-$21K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$14.7K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$8.68K |
| 5 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
-$8.51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $8K | +$18K | +2,031 | New |
|
|
MCG
2
McCollum Christoferson Group
Amherst,
New York
| $7.67K | +$9.69K | +1,094 | +145% |
|
|
VCWA
3
Vanguard Capital Wealth Advisors
Denver,
Colorado
| $6.92K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $6.18K | -$14.7K | -1,658 | -53% |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $6.09K | +$13K | +1,467 | New |
|
|
VF
6
Virtu Financial
New York
| – | -$21K | -1,565 | Closed |
|
|
PAG
7
Private Advisor Group
Morristown,
New Jersey
| – | -$8.68K | -680 | Closed |
|
|
IAA
8
Independent Advisor Alliance
Charlotte,
North Carolina
| – | -$8.51K | -667 | Closed |
|
9
Bank of America
Charlotte,
North Carolina
| – | -$102 | -8 | Closed |
|
|
DGAM
10
Desjardins Global Asset Management
Montreal,
Quebec, Canada
| – | -$25.1K | -8 | Closed |
|
11
UBS Group
Zurich,
Switzerland
| – | -$50 | -4 | Closed |
|
MGRX Hedge Fund Activity: Q4 2023 in Review
5 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q4 2023, worth a combined $34.9K — down 74% from $136K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MGRX and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $18K. The largest seller was Desjardins Global Asset Management, exiting entirely with an estimated $25.1K sold.
- 5 institutional investors held Mangoceuticals (MGRX) as of Q4 2023, down from 9 in Q3 2023.
- Funds reported $34.9K of Mangoceuticals stock for Q4 2023, down 74% quarter-over-quarter.
- 2 funds opened new Mangoceuticals positions in Q4 2023 and 6 closed out, a net change of -4 holders.
- The largest Mangoceuticals buyer in Q4 2023 was Renaissance Technologies, an estimated $18K added.
- The largest Mangoceuticals seller in Q4 2023 was Desjardins Global Asset Management, an estimated $25.1K sold.
Based on aggregated 13F filings for Q4 2023.